Ticlopidine-induced prolonged cholestasis: A case report

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 6, 1999, Pages 673-676

  Amaro, Pedro ^a   Nunes, Amadeu ^a   Maçôas, Fernanda ^a   Ministro, Paula ^a   Baranda, Joao ^a   Cipriano, Augusta ^a   Martins, Irene ^a   Rosa, Albano ^a   Pimenta, Isidoro ^a   Donato, António ^a   Freitas, Diniz ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Drug induced prolonged cholestasis; Ticlopidine

Indexed keywords

AMIODARONE; ANTITHROMBOCYTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT; TICLOPIDINE;

ABDOMINAL PAIN; ADULT; ARTICLE; BILE DUCT INJURY; CASE REPORT; CHOLESTASIS; DISEASE COURSE; DISEASE SEVERITY; HEART ARRHYTHMIA; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; PRURITUS; SYMPTOM;

EID: 0032804247     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199906000-00015     Document Type: Article

References (36)

1. 1 McTavish D, Faulds D, Goa KL. Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 1990; 40:238-259.
2. 2 Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinsky VC, Harbinson JW, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989; i:1215-1220.
3. 3 Hass WK, Easton JD, Adams HP, Pryse-Phillips W, Molony BA, Anderson S, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321:501-507.
4. 4 Janzen L, Berqvuist D, Boberg J. et al. Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study. J Intern Med 1990; 227:301-308.
5. 5 Deschamps J, Lasségue A, Ottingnon Y, Vuitton D, Allemand H, Carayon P, et al. lectère cholestatique associé ȧ la prise de ticlopidine: à propos des deux premiers cas. Gastroenterol Clin Biol 1982; 6:595-596.
6. 6 Saint-Marc Girardin M, Cordonnier C. Ictère cholestatique et agranulocytose dus ȧ la ticlopidine. Gastroenterol Clin Biol 1982; 6:716-717.
7. 7 Biour M, Toussaint P, Duhamel G, Canuel C, Krulick M, Calmus Y, Ticlopidine: atteintes sanguines et hépatiques? Thérapíe 1982; 37:222-224.
8. 8 Eugene C, Lefevre JF, Gury B, Quevauttiers J. Hépatite cholestatique: rôle vraisemblable de la ticlopidine. Semin Hop Paris 1983; 59:2923-2924.
9. 9 Pistone AM, Podestá F, Raviolo E, Testa D, Grosso B, Toselli P. Epatosteatosi colestatica di probable origine iatrogena. Recenti Prog Med 1986; 77:188-190.
10. 10 Mammaretta A, Paoletti V, Moroni C, Cassone R. Ittero colestatico da ticlopidina. Clin Ter 1991; 138:45-46.
11. 11 Miyahara K, Kasahara N, Kondo Y, Imai Y, Matuzaki F. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis. Jpn J Med 1991; 30:354-359.
12. 12 Sondag D, Bader R, Claude P, Schreiber M. Hépatite à la ticlopidine: un nouveau cas. Ann Gastroenterol Hepatol 1993; 29:40-41.
13. 13 Greaney JJ, Hess DA, Mahoney CD. Ticlopidine-induced cholestatic jaundice [Letter]. Clin Pharm 1993; 12:398-399.
14. 14 Nurhussein MA. Ticlopidine-induced prolonged cholestasis. J Am Geriatr Soc 1993; 41:1371-1372.
15. 15 Corrales J, Herraez A, Cejudo D. Ictericia colestática secundaria a ticlopidina. An Med Intern 1993; 10:621-622.
16. 16 Weber E, Donckier J. Ictère cholestatique sur ticlopidine: un nouveau cas. Acta Clin Belg 1994; 49:309-310.
17. 17 Grimm I, Litynski J. Severe cholestasis associated with ticlopidine. Am J Gastroenterol 1994; 89:279-280.
18. 18 Colivicchi F, Magnanimi S, Sebastiani F, Silvestri R, Magnanimi R. Ticlopidine-induced chronic cholestatic hepatitis: a case report. Curr Ther Res 1994; 55:929-931.
19. 19 Alvaro D, Gigliozzi A, Gaudio E, Pescarmona E, Ripani M, Peri C. Ticlopidine-induced cholestasis: report of two cases and experimental evidence of the drug's adverse effect in isolated perfused rat liver. Eur J Gastroenterol Hepatol 1994; 6:934-950.
20. 20 Lopez P, Castiella A, Bujanda L, Arenas J. Hepatitis colestática por ticlopidina. Presentacion de un nuevo caso. Rev Esp Enferm Dig 1995; 87:735-737.
21. 21 Roy L, Plante MA, Perreault H, Biron P. Cholestalic hepatitis: ticlopidine suspected [Letter]. Therapie 1995; 50: 593-594.
22. 22 Ruiz-Valverde P, Zafon C, Segarra A, Ribera R, Piera L. Ticlopidine-induced granulomatous hepatitis [Letter]. Ann Pharmacother 1995; 29:633-634.
23. 23 Parra FJ, Jimenez FJ, Contreras T, Romera M. Hepatitis colestática por ticlopidina [Letter]. Rev Esp Enferm Dig 1995; 87:414-415.
24. 24 Cassidy LJ, Schuster BG, Halparin LS. Probable ticlopidine-induced cholestatic hepatitis. Ann Pharmacother 1995; 29:30-32.
25. 25 Pascual S, Sarriȯn JV, Jarque l, Argüelo L, Berenguer J. Hepatitis colestática y anemia por ticlopidina. Gastroentol Hepatol 1996; 19:208-209.
26. 26 Veldhuyzen van Zanten S, McCormick CW. Antinuclear antibody-positive ticlopidine-induced hepatitis. Can J Gastroenterol 1996; 10:231-232.
27. 27 Portugal F, Saez J, Manchado J, Solsona F. Hepatitis colestásica por ticlopidina: presentacion de un nuevo caso. An Med Intern 1997; 14:540-541.
28. 28 Yim HB, Lieu PK, Choo PW. Ticlopidine induced cholestatic jaundice. Singapore Med J 1997; 38:132-133.
29. 29 Guzzini F, Banfi L, Gomitoni A, Marchegiani C, Novati P, Mesina M, et al. Due casi di colestasi acuta da ticlopidina. Recenti Prog Med 1997; 88:124-127.
30. 30 Fuenzalida A, Socin H, Laudano O, Avagnina A, Findor JA. Colestasis asociada a ticlopidina. Gastroenterol Hepatol 1997; 20:128-130.
31. 31 Larrey D, Erlinger S. Drug-induced cholestasis, Baillières Clin Gastroenterol 1988; 2:423-452.
32. 32 Maluish AE, Strong DM, Lymphocyte proliferation. In: Manual of Clinical and Laboratory Immunology. Rose NR, Friedman U, Fahey JL (editors). Washington: American Society for Microbiology; 1986. pp. 274-289.
33. 33 Shirai M, Hanada H, Kurokouchi K, Watanabe S, Nishioka M. Peripheral blood CD4-mediated enhancement and CD8-mediated suppression on the presence of recombinant hepatitis core antigen. J Infect Dis 1990; 161:420-425.
34. 34 International Consensus Meeting. Criteria of drug-induced liver disorders. J Hepatol 1990; 11:272-276.
35. 35 Zimmerman HJ, Maddrey W. Toxic and drug-induced hepatitis. In: Diseases of the Liver. Schiff L, Schiff ER (editors). Philadelphia: JB Lippincott; 1993. pp. 707-787.
36. 36 Zimmerman HJ. Hepatotoxicity: the Adverse Effects of Drugs and Other Chemicals on the Liver. New York: Appleton-Century-Crofts; 1978.